{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T16:35:52Z","timestamp":1780590952791,"version":"3.54.1"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.atherosclerosis.2021.05.017","type":"journal-article","created":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T12:30:33Z","timestamp":1622118633000},"page":"38-43","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Association between vascular endothelial dysfunction and the inflammatory marker neopterin in patients with classic congenital adrenal hyperplasia"],"prefix":"10.1016","volume":"328","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1904-7170","authenticated-orcid":false,"given":"Hekma Saad","family":"Farghaly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4763-488X","authenticated-orcid":false,"given":"Kotb Abbass","family":"Metwalley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duaa Mohamed","family":"Raafat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghada Mohamed","family":"Saied","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magda Farghali","family":"Gabri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6806-9042","authenticated-orcid":false,"given":"Magdy","family":"Algowhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.atherosclerosis.2021.05.017_bib1","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1210\/jc.2018-01865","article-title":"Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an endocrine society clinical practice guideline","volume":"103","author":"Speiser","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"10","key":"10.1016\/j.atherosclerosis.2021.05.017_bib2","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/s41431-020-0653-5","article-title":"EMQN best practice guidelines for molecular genetic testing and reporting of 21-hydroxylase deficiency","volume":"28","author":"Baumgartner-Parzer","year":"2020","journal-title":"Eur. J. Hum. Genet."},{"issue":"9","key":"10.1016\/j.atherosclerosis.2021.05.017_bib3","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1210\/JC.2015-2093","article-title":"Increased cardiovascular and metabolic morbidity in patients with 21-hydroxylase deficiency: a Swedish population-based national cohort study","volume":"100","author":"Falhammar","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2021.05.017_bib4","doi-asserted-by":"crossref","first-page":"e98","DOI":"10.1542\/peds.2005-1005","article-title":"Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"117","author":"V\u00f6lkl","year":"2006","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2021.05.017_bib5","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1210\/jcem.87.5.8456","article-title":"Children with classic congenital adrenal hyperplasia have elevated serum leptin concentrations and insulin resistance: potential clinical implications","volume":"87","author":"Charmandari","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2021.05.017_bib6","doi-asserted-by":"crossref","first-page":"e957","DOI":"10.1210\/clinem\/dgaa801","article-title":"Reproductive and perinatal outcomes in women with congenital adrenal hyperplasia: a population-based cohort study","volume":"106","author":"Hirschberg","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2021.05.017_bib7","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1159\/000492900","article-title":"Homocysteine level in children with classic congenital adrenal hyperplasia: relationship to carotid intimal wall thickness and left ventricular function","volume":"90","author":"Metwalley","year":"2018","journal-title":"Horm. Res. Paediatr."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2021.05.017_bib8","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00431-015-2634-1","article-title":"Left ventricular dysfunction and subclinical atherosclerosis in children with classic congenital adrenal hyperplasia: a single-center study from upper Egypt","volume":"175","author":"Metwalley","year":"2016","journal-title":"Eur. J. Pediatr."},{"issue":"12","key":"10.1016\/j.atherosclerosis.2021.05.017_bib9","doi-asserted-by":"crossref","first-page":"E2715","DOI":"10.1210\/jc.2014-2957","article-title":"Increased mortality in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"99","author":"Falhammar","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"Suppl 3","key":"10.1016\/j.atherosclerosis.2021.05.017_bib10","first-page":"411","article-title":"Childhood-onset congenital adrenal hyperplasia: long-term outcome and optimization of therapy","volume":"17","author":"Labarta","year":"2004","journal-title":"J. Pediatr. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2021.05.017_bib11","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.ando.2007.06.019","article-title":"Hormonal treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"68","author":"Bachelot","year":"2007","journal-title":"Ann. Endocrinol."},{"issue":"7","key":"10.1016\/j.atherosclerosis.2021.05.017_bib12","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1161\/CIRCULATIONAHA.108.765701","article-title":"Endothelial function predicts progression of carotid intima-media thickness","volume":"119","author":"Halcox","year":"2009","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2021.05.017_bib13","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1590\/2359-3997000000281","article-title":"Impaired flow-mediated dilation response and carotid intima-media thickness in patients with type 1 diabetes mellitus with a mean disease duration of 4.1 years","volume":"61","author":"Tacito","year":"2017","journal-title":"Arch. Endocrinol. Metab."},{"issue":"8","key":"10.1016\/j.atherosclerosis.2021.05.017_bib14","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00011-003-1181-9","article-title":"Potential role of immune system activation-associated production of neopterin derivatives in humans","volume":"52","author":"Hoffmann","year":"2003","journal-title":"Inflamm. Res."},{"issue":"35","key":"10.1016\/j.atherosclerosis.2021.05.017_bib15","doi-asserted-by":"crossref","first-page":"4644","DOI":"10.2174\/092986709789878247","article-title":"The role of neopterin in atherogenesis and cardiovascular risk assessment","volume":"16","author":"Fuchs","year":"2009","journal-title":"Curr. Med. Chem."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2021.05.017_bib16","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.beem.2008.10.010","article-title":"Management of the child with congenital adrenal hyperplasia","volume":"23","author":"Hindmarsh","year":"2009","journal-title":"Best Pract. Res. Clin. Endocrinol. Metabol."},{"issue":"2 Suppl 4th Report","key":"10.1016\/j.atherosclerosis.2021.05.017_bib17","first-page":"555","article-title":"National high blood pressure education program working group on high blood pressure in children and adolescents","volume":"114","author":"American Academy of Pediatrics","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.atherosclerosis.2021.05.017_bib18","author":"Diabetes Endocrine Metabolism Pediatric Unit"},{"key":"10.1016\/j.atherosclerosis.2021.05.017_bib19","series-title":"Growth at Adolescence","author":"Tanner","year":"1962"},{"key":"10.1016\/j.atherosclerosis.2021.05.017_bib20","series-title":"Radiographic Atlas of Skeletal Development of the Hand and Wrist","author":"Greulich","year":"1959"},{"key":"10.1016\/j.atherosclerosis.2021.05.017_bib21","first-page":"783296","article-title":"Healthy Chilean adolescents with HOMA-IR \u2265 2.6 have increased cardiometabolic risk: association with genetic, biological, and environmental factors","author":"Burrows","year":"2015","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.atherosclerosis.2021.05.017_bib22","first-page":"e52070","article-title":"Ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery in clinical research","volume":"92","author":"Alley","year":"2014","journal-title":"JoVE"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2021.05.017_bib23","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1097\/00004424-200012000-00001","article-title":"Ultrasound assessment of atherosclerotic vessel wall changes: reproducibility of intima-media thickness measurements in carotid and femoral arteries","volume":"35","author":"Sr\u00e1mek","year":"2000","journal-title":"Invest. Radiol."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2021.05.017_bib24","doi-asserted-by":"crossref","first-page":"493","DOI":"10.2337\/diabetes.51.2.493","article-title":"Carotid artery intima-media thickness in children with type 1 diabetes","volume":"51","author":"J\u00e4rvisalo","year":"2002","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2021.05.017_bib25","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1111\/j.1365-2265.2011.04309.x","article-title":"Adolescents with congenital adrenal hyperplasia because of 21-hydroxylase deficiency have vascular dysfunction","volume":"76","author":"Harrington","year":"2012","journal-title":"Clin. Endocrinol."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2021.05.017_bib26","first-page":"505","article-title":"Vascular and cardiac function in young adults with classical congenital adrenal hyperplasia","volume":"68","author":"Wierzbicka-Chmiel","year":"2017","journal-title":"Endokrynol. Pol."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2021.05.017_bib27","first-page":"68","article-title":"The role of neopterin in cardiovascular disease","volume":"68","author":"Pacileo","year":"2007","journal-title":"Monaldi Arch. Chest Dis."},{"issue":"10","key":"10.1016\/j.atherosclerosis.2021.05.017_bib28","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1111\/j.1538-7836.2006.02125.x","article-title":"Neopterin induces pro-atherothrombotic phenotype in human coronary endothelial cells","volume":"4","author":"Cirillo","year":"2006","journal-title":"J. Thromb. Haemostasis"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2021.05.017_bib29","doi-asserted-by":"crossref","first-page":"e007359","DOI":"10.1161\/JAHA.117.007359","article-title":"Neopterin counters vascular inflammation and atherosclerosis","volume":"7","author":"Shirai","year":"2018","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.atherosclerosis.2021.05.017_bib30","first-page":"1","article-title":"Neopterin derivatives - a novel therapeutic target rather than biomarker for atherosclerosis and related diseases","volume":"14","author":"Watanabe","year":"2020","journal-title":"Vasa"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2021.05.017_bib31","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/jhh.2015.72","article-title":"Increased plasma neopterin levels are associated with reduced endothelial function and arterial elasticity in hypertension","volume":"30","author":"Zhang","year":"2016","journal-title":"J. Hum. Hypertens."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2021.05.017_bib32","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41443-019-0163-6","article-title":"Effect of treatment with testosterone on endothelial function in hypogonadal men: a systematic review and meta-analysis","volume":"32","author":"Sansone","year":"2020","journal-title":"Int. J. Impot. Res."},{"issue":"7","key":"10.1016\/j.atherosclerosis.2021.05.017_bib33","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1089\/jwh.2018.7441","article-title":"Endogenous sex hormones and endothelial function in postmenopausal women and men: the multi-ethnic study of atherosclerosis","volume":"28","author":"Mathews","year":"2019","journal-title":"J. Womens Health (Larchmt)"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2021.05.017_bib34","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.atherosclerosis.2009.10.037","article-title":"Low testosterone level as a predictor of cardiovascular events in Japanese men with coronary risk factors","volume":"210","author":"Akishita","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2021.05.017_bib35","doi-asserted-by":"crossref","first-page":"840","DOI":"10.3389\/fphys.2020.00840","article-title":"Exercise, cardiovascular health, and risk factors for atherosclerosis: a narrative review on these complex relationships and caveats of literature","volume":"11","author":"Santos","year":"2020","journal-title":"Front. Physiol."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2021.05.017_bib36","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.atherosclerosis.2011.02.044","article-title":"Angiotensin converting enzyme inhibitors effect on endothelial dysfunction: a meta-analysis of randomised controlled trials","volume":"216","author":"Shahin","year":"2011","journal-title":"Atherosclerosis"},{"issue":"13","key":"10.1016\/j.atherosclerosis.2021.05.017_bib37","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.4103\/0366-6999.208231","article-title":"Relation of biochemical parameters with flow-mediated dilatation in patients with metabolic syndrome","volume":"130","author":"Sipahioglu","year":"2017","journal-title":"Chin. Med. J."},{"issue":"10","key":"10.1016\/j.atherosclerosis.2021.05.017_bib38","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.mayocp.2012.07.004","article-title":"Comparison of the effect of the metabolic syndrome and multiple traditional cardiovascular risk factors on vascular function","volume":"87","author":"Li","year":"2012","journal-title":"Mayo Clin. Proc."},{"issue":"16","key":"10.1016\/j.atherosclerosis.2021.05.017_bib39","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1161\/01.CIR.0000096055.62724.C5","article-title":"Inflammatory cytokines stimulated C-reactive protein production by human coronary artery smooth muscle cells","volume":"108","author":"Calabr\u00f3","year":"2003","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2021.05.017_bib40","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1177\/1358863X09106869","article-title":"Novel markers of peripheral arterial disease","volume":"14","author":"Khawaja","year":"2009","journal-title":"Vasc. Med."},{"issue":"9","key":"10.1016\/j.atherosclerosis.2021.05.017_bib41","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1161\/ATVBAHA.120.314824","article-title":"Fibrosis and inflammatory markers and long-term risk of peripheral artery disease: the ARIC study","volume":"40","author":"Ding","year":"2020","journal-title":"Arterioscler. Thromb. Vasc. Biol."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915021002537?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915021002537?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T16:26:02Z","timestamp":1762187162000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915021002537"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":41,"alternative-id":["S0021915021002537"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2021.05.017","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between vascular endothelial dysfunction and the inflammatory marker neopterin in patients with classic congenital adrenal hyperplasia","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2021.05.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}